BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 31355524)

  • 1. The establishment of immune infiltration based novel recurrence predicting nomogram in prostate cancer.
    Meng J; Liu Y; Guan S; Fan S; Zhou J; Zhang M; Liang C
    Cancer Med; 2019 Sep; 8(11):5202-5213. PubMed ID: 31355524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of recurrence marker associated with immune infiltration in prostate cancer with radical resection and build prognostic nomogram.
    Rui X; Shao S; Wang L; Leng J
    BMC Cancer; 2019 Dec; 19(1):1179. PubMed ID: 31795990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A model based on tumor-infiltrating immune cells for predicting the relapse rates of patients with testicular germ cell tumors.
    Wang Y; Ji C; Liu J; Wang Y; Song N; Cao P
    Int Immunopharmacol; 2020 Sep; 86():106710. PubMed ID: 32652500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Analysis of Tumor-Infiltrating Immune Cells and Relevant Therapeutic Strategy in Esophageal Cancer.
    Lu G; Chen L; Wu S; Feng Y; Lin T
    Dis Markers; 2020; 2020():8974793. PubMed ID: 32454908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploration of the Tumor Mutational Burden as a Prognostic Biomarker and Related Hub Gene Identification in Prostate Cancer.
    Wang L; Yao Y; Xu C; Wang X; Wu D; Hong Z
    Technol Cancer Res Treat; 2021; 20():15330338211052154. PubMed ID: 34806485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A gene expression-based study on immune cell subtypes and glioma prognosis.
    Zhong QY; Fan EX; Feng GY; Chen QY; Gou XX; Yue GJ; Zhang GH
    BMC Cancer; 2019 Nov; 19(1):1116. PubMed ID: 31729963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploration of gene expression profiles and immune microenvironment between high and low tumor mutation burden groups in prostate cancer.
    Luo C; Chen J; Chen L
    Int Immunopharmacol; 2020 Sep; 86():106709. PubMed ID: 32593155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune cell analyses of the tumor microenvironment in prostate cancer highlight infiltrating regulatory T cells and macrophages as adverse prognostic factors.
    Andersen LB; Nørgaard M; Rasmussen M; Fredsøe J; Borre M; Ulhøi BP; Sørensen KD
    J Pathol; 2021 Oct; 255(2):155-165. PubMed ID: 34255349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a Novel Nomogram to Predict Progression Based on the Circadian Clock and Insights Into the Tumor Immune Microenvironment in Prostate Cancer.
    Feng D; Xiong Q; Zhang F; Shi X; Xu H; Wei W; Ai J; Yang L
    Front Immunol; 2022; 13():777724. PubMed ID: 35154101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-Infiltrating Immune Cells Act as a Marker for Prognosis in Colorectal Cancer.
    Ye L; Zhang T; Kang Z; Guo G; Sun Y; Lin K; Huang Q; Shi X; Ni Z; Ding N; Zhao KN; Chang W; Wang J; Lin F; Xue X
    Front Immunol; 2019; 10():2368. PubMed ID: 31681276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profiles of immune cell infiltration in head and neck squamous carcinoma.
    Liang B; Tao Y; Wang T
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32095823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
    Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
    Front Immunol; 2019; 10():6. PubMed ID: 30761122
    [No Abstract]   [Full Text] [Related]  

  • 13. Gene expression-based immune infiltration analyses of renal cancer and their associations with survival outcome.
    Chen L; Yin L; Qi Z; Li J; Wang X; Ma K; Liu X
    BMC Cancer; 2021 May; 21(1):595. PubMed ID: 34030645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of osteosarcoma.
    Zhang C; Zheng JH; Lin ZH; Lv HY; Ye ZM; Chen YP; Zhang XY
    Aging (Albany NY); 2020 Feb; 12(4):3486-3501. PubMed ID: 32039832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor infiltrating M2 macrophages could predict biochemical recurrence of localized prostate cancer after radical prostatectomy.
    Zhang Q; Xia J; Wang Y; Zhang J; Ji C; Cong R; Wang Y; Song N
    Exp Cell Res; 2019 Nov; 384(1):111588. PubMed ID: 31473209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating the significance of tumor-infiltrating immune cells for the prognosis of lung squamous cell carcinoma.
    Zhu Y; Zhang X
    PeerJ; 2019; 7():e7918. PubMed ID: 31667016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of Tumor-Infiltrating Immune Cells in the Prognosis of Colon Cancer.
    Wu D; Ding Y; Wang T; Cui P; Huang L; Min Z; Xu M
    Onco Targets Ther; 2020; 13():4581-4589. PubMed ID: 32547088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value and potential mechanism of Matrix Metalloproteinases among Prostate Cancer.
    Geng X; Chen C; Huang Y; Hou J
    Int J Med Sci; 2020; 17(11):1550-1560. PubMed ID: 32669958
    [No Abstract]   [Full Text] [Related]  

  • 19. The Landscape of Immune Cells Infiltrating in Prostate Cancer.
    Wu Z; Chen H; Luo W; Zhang H; Li G; Zeng F; Deng F
    Front Oncol; 2020; 10():517637. PubMed ID: 33194581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Implications of Heterogeneity in Intra-tumoral Immune Composition for Recurrence in Early Stage Lung Cancer.
    Mony JT; Schuchert MJ
    Front Immunol; 2018; 9():2298. PubMed ID: 30374348
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.